ACCB contains biomaterials and plant-derived anti-oxidant concoction for skin and scalp tissue regeneration.

ACCB, Advanced cord blood-derived mesenchymal stem cell-derived cell booster for Skin & Hair.

Specially designed ACCB Skin and Hair are based on an advanced stem cell technology with biomimetic peptides, antioxidants, and nutriment concoction for restoring skin and hair cells that were affected by the aging process of internal and external factors.

Introduction-Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) 

Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) have been suggested to promote tissue repair and have been used for tissue engineering in numerous studies. Not only can their multiple lineages replace aged or damaged cells, but their secretory factors can enhance tissue repair efficiency.

PATENT, W O 2017/123022

UCB-MSCs provide a high amount of growth factors

Stem cell-derived exosomes containing a high amount of growth factors

The protein expression level of EGF (epidermal growth factor), FGF (fibroblast growth factor), VEGF (vascular endothelial growth factor), TGF (transforming growth factor ), PDGF (platelet-derived growth factor), HGF (hepatocyte growth factor) was tested in the conditioned media of UCB, AD (adipose), and BM (bone marrow), Result shows the UCB-MSC exosome contains a higher level of growth factors compare with the exosome of AD and BM.


Promotes ECMs gene expression


Suppresses melanogenesis



Experimental data is our own test
Experimental data is our own test

Use UCB-MSCs to determine the effects of both stem cells and their paracrine factors on reacquisition of hDPC (human dermal papilla cells) conduction ability to induce hair growth and to provide an effective therapeutic strategy for alopecia

UCB-MSCs promote hair follicle cycling, morphogenesis in vivo

hUCB-MSCs promoted the telogen-anagen transition, in particular, hair follicles that were treated with UCB-MSCs were transformed from the telogen phase to the early-and middle -anagen phases at 6 weeks.